Etanercept Market Share and Growth Analysis by Application
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. Over production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
View full press release